LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...
LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...
LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
s Early diagnosis <strong>of</strong> persons with an increased risk for<br />
schizophrenia through <strong>the</strong> use <strong>of</strong> an early diagnosis<br />
inventory.<br />
s The prevention <strong>of</strong> disease onset by early psychological<br />
and pharmacological treatment <strong>of</strong> at-risk persons.<br />
s The optimisation <strong>of</strong> acute and long-term treatment <strong>of</strong><br />
first-episode schizophrenia.<br />
Special project networks<br />
Projects on General Topics<br />
PAN I<br />
Early recognition and<br />
early intervention<br />
Optimisation<br />
<strong>of</strong> early recognition<br />
Development and evaluation <strong>of</strong><br />
an early recognition inventory<br />
Biological basis <strong>of</strong> <strong>the</strong> risk <strong>of</strong><br />
disorder<br />
Psychological early inter-<br />
vention in early prodromal<br />
stages<br />
Pharmacological and<br />
psychological early inter-<br />
vention in late prodromal<br />
stages<br />
Biological basis <strong>of</strong> early<br />
intervention<br />
PN II SN 1<br />
Acute treatment and care<br />
Optimisation<br />
<strong>of</strong> acute treatment<br />
Drug treatment in first-<br />
episode schizophrenia<br />
Guideline-supported quality<br />
management<br />
PN II SN 2<br />
Long-term treatment<br />
and care<br />
Optimisation<br />
<strong>of</strong> <strong>the</strong> long-term treatment<br />
<strong>of</strong> first episodes<br />
Long-term drug-treatment<br />
strategies<br />
Psychological intervention<br />
strategies<br />
Prodrome-based relapse<br />
prevention and early<br />
intervention<br />
Biological basis <strong>of</strong> relapses<br />
Functional brain indicators<br />
<strong>of</strong> risk <strong>of</strong> relapse<br />
Molecular and pharmacogenetics<br />
Health economics/Public Education/Education, including Continuing Medical Education/<br />
Quality assurance/Documentation and methodology<br />
Figure 5: Research projects <strong>of</strong> <strong>the</strong> Competence Network on Schizophrenia; PN = Project Network, SN= Sub-netwok<br />
PN II SN 3<br />
ReseaRch<br />
s Relapse prevention by improved relapse prediction and<br />
early intervention.<br />
s Improve quality <strong>of</strong> care through <strong>the</strong> use <strong>of</strong> treatment<br />
guidelines for outpatients and inpatients.<br />
s The prevention <strong>of</strong> chronification through targeted<br />
rehabilitation.<br />
s Investigation <strong>of</strong> <strong>the</strong> brain-biological and genetic<br />
principles <strong>of</strong> <strong>the</strong> disorder.<br />
Collection and optimisation<br />
<strong>of</strong> outpatient treatment and care<br />
Acute course and 2-year course<br />
under current treatment conditions<br />
Optimisation <strong>of</strong> treatment in<br />
general medical practice<br />
Quality management in<br />
psychiatrists’ practices<br />
Therapeutic drug monitoring<br />
Rehabilitation <strong>of</strong> residual<br />
processes<br />
Optimisation <strong>of</strong> <strong>the</strong><br />
rehabilitation <strong>of</strong> patients<br />
with residual courses<br />
Biological basis <strong>of</strong> drug<br />
treatment<br />
Functional brain-indicators<br />
<strong>of</strong> negative symptoms<br />
Psychological interventions<br />
in cognitive and emotional<br />
disorders<br />
Evaluation <strong>of</strong> occupational<br />
rehabilitation measures<br />
59